Artificial Intelligence powered epilepsy diagnostics

Project description

Technological advances improve classification of seizure types

The most common serious brain disorder worldwide, epilepsy affects more than 65 million people, including six million in Europe alone. Recent studies show that, if properly treated, up to 70 % of people who suffer from seizures could live productive and fulfilling lives. However, effective treatment hinges on the limitations of current diagnostic methods. Therefore, improving these methods in order to select the best treatment is key. The EU-funded EPINOSTICS project will develop new technology that can automatically detect and classify all motor seizure types and deliver important health benefits globally. The aim is to improve treatment options so that epilepsy is prevented from impairing the physical, psychological and social functioning of those affected.

Fields of science

• engineering and technology › electrical engineering, electronic engineering, information engineering › electronic engineering › sensors › optical sensors
• natural sciences › computer and information sciences › artificial intelligence › machine learning › deep learning
• medical and health sciences › basic medicine › neurology › epilepsy
• social sciences › economics and business › business and management › commerce

Programme(s)

• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020-3
See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)

Coordinator

NEURO EVENT LABS OY

Address

Biokatu 10
33520 Tampere
Finland

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 1 881 250